Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on perso...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full |
| _version_ | 1828732097219526656 |
|---|---|
| author | Zhenglin Chang Zhenglin Chang Zhenglin Chang Rongqi Li Jinhu Zhang Lingyue An Gaoxiang Zhou Gaoxiang Zhou Min Lei Jiwang Deng Riwei Yang Zhenfeng Song Zhenfeng Song Wen Zhong Defeng Qi Xiaolu Duan Shujue Li Baoqing Sun Wenqi Wu Wenqi Wu |
| author_facet | Zhenglin Chang Zhenglin Chang Zhenglin Chang Rongqi Li Jinhu Zhang Lingyue An Gaoxiang Zhou Gaoxiang Zhou Min Lei Jiwang Deng Riwei Yang Zhenfeng Song Zhenfeng Song Wen Zhong Defeng Qi Xiaolu Duan Shujue Li Baoqing Sun Wenqi Wu Wenqi Wu |
| author_sort | Zhenglin Chang |
| collection | DOAJ |
| description | Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on personalized immune and inflammatory characteristics. H&E-stained histopathology images confirmed the distinct infiltration of immune and inflammatory cells among clusters. Cluster-A was characterized by a favorable prognosis and low immune and inflammatory infiltration but showed the highest abundance of prognosis-related favorable immune cell and inflammatory activity. Cluster-B featured the worst prognosis and high immune infiltration, but numerous unfavorable immune cells exist. Cluster-C had a favorable prognosis and the highest immune and inflammatory infiltration. Based on machine learning, a highly precise predictive model (immune and inflammatory responses signature, IIRS), including FN1, IL10, MYC, CD247, and TLR2, was developed and validated to identify the high IIRS-score group that had a poor prognosis and advanced clinical characteristics. Compared to other published models, IIRS showed the highest AUC in 5 years of overall survival (OS) and a favorable predictive value in predicting 1- and 3- year OS. Moreover, IIRS showed an excellent performance in predicting immunotherapy and chemotherapy’s response. According to immunohistochemistry and qRT-PCR, IIRS genes were differentially expressed between tumor tissues with corresponding normal or adjacent tissues. Finally, immunohistochemical and H&E-stained analyses were performed on the bladder tissues of 13 BLCA patients to further demonstrate that the IIRS score is a valid substitute for IIR patterns and can contribute to identifying patients with poor clinical and histopathology characteristics. In conclusion, we established a novel IIRS depicting an IIR pattern that could independently predict OS and acts as a highly precise predictive biomarker for advanced clinical characters and the responses to immunotherapy and chemotherapy. |
| first_indexed | 2024-04-12T17:56:03Z |
| format | Article |
| id | doaj.art-e793c3f461104d5599ea650a03e649bd |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-12T17:56:03Z |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-e793c3f461104d5599ea650a03e649bd2022-12-22T03:22:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10088651008865Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patientsZhenglin Chang0Zhenglin Chang1Zhenglin Chang2Rongqi Li3Jinhu Zhang4Lingyue An5Gaoxiang Zhou6Gaoxiang Zhou7Min Lei8Jiwang Deng9Riwei Yang10Zhenfeng Song11Zhenfeng Song12Wen Zhong13Defeng Qi14Xiaolu Duan15Shujue Li16Baoqing Sun17Wenqi Wu18Wenqi Wu19Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Hepatobiliary Surgery, Foshan Hospital of Traditional Chinese Medical, Foshan, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Allergy and Clinical Immunology, Department of Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDue to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on personalized immune and inflammatory characteristics. H&E-stained histopathology images confirmed the distinct infiltration of immune and inflammatory cells among clusters. Cluster-A was characterized by a favorable prognosis and low immune and inflammatory infiltration but showed the highest abundance of prognosis-related favorable immune cell and inflammatory activity. Cluster-B featured the worst prognosis and high immune infiltration, but numerous unfavorable immune cells exist. Cluster-C had a favorable prognosis and the highest immune and inflammatory infiltration. Based on machine learning, a highly precise predictive model (immune and inflammatory responses signature, IIRS), including FN1, IL10, MYC, CD247, and TLR2, was developed and validated to identify the high IIRS-score group that had a poor prognosis and advanced clinical characteristics. Compared to other published models, IIRS showed the highest AUC in 5 years of overall survival (OS) and a favorable predictive value in predicting 1- and 3- year OS. Moreover, IIRS showed an excellent performance in predicting immunotherapy and chemotherapy’s response. According to immunohistochemistry and qRT-PCR, IIRS genes were differentially expressed between tumor tissues with corresponding normal or adjacent tissues. Finally, immunohistochemical and H&E-stained analyses were performed on the bladder tissues of 13 BLCA patients to further demonstrate that the IIRS score is a valid substitute for IIR patterns and can contribute to identifying patients with poor clinical and histopathology characteristics. In conclusion, we established a novel IIRS depicting an IIR pattern that could independently predict OS and acts as a highly precise predictive biomarker for advanced clinical characters and the responses to immunotherapy and chemotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/fullbladder cancerchemotherapyimmunotherapyimmune and inflammatory characteristicsunsupervised cluster analysis |
| spellingShingle | Zhenglin Chang Zhenglin Chang Zhenglin Chang Rongqi Li Jinhu Zhang Lingyue An Gaoxiang Zhou Gaoxiang Zhou Min Lei Jiwang Deng Riwei Yang Zhenfeng Song Zhenfeng Song Wen Zhong Defeng Qi Xiaolu Duan Shujue Li Baoqing Sun Wenqi Wu Wenqi Wu Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients Frontiers in Immunology bladder cancer chemotherapy immunotherapy immune and inflammatory characteristics unsupervised cluster analysis |
| title | Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| title_full | Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| title_fullStr | Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| title_full_unstemmed | Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| title_short | Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| title_sort | distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients |
| topic | bladder cancer chemotherapy immunotherapy immune and inflammatory characteristics unsupervised cluster analysis |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full |
| work_keys_str_mv | AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT zhenglinchang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT rongqili distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT jinhuzhang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT lingyuean distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT gaoxiangzhou distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT gaoxiangzhou distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT minlei distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT jiwangdeng distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT riweiyang distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT zhenfengsong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT zhenfengsong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT wenzhong distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT defengqi distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT xiaoluduan distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT shujueli distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT baoqingsun distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT wenqiwu distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients AT wenqiwu distinctimmuneandinflammatoryresponsepatternscontributetotheidentificationofpoorprognosisandadvancedclinicalcharactersinbladdercancerpatients |